This episode features Kristen McDermott Woodrum, Partner at McGuireWoods LLP. Here, she discusses the DEA & HHS announcing they are extending pandemic-era flexibilities for prescribing controlled substances via telehealth through the end of 2024.
This episode features Kristen McDermott Woodrum, Partner at McGuireWoods LLP. Here, she discusses the DEA & HHS announcing they are extending pandemic-era flexibilities for prescribing controlled substances via telehealth through the end of 2024.